Erratum: HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment (Proceedings of the National Academy of Sciences of the United States of America (2008) 105 (19183-19187) DOI: 10.1073/pnas.0805514105))